Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 165   

Articles published

PFE 32.80 +0.35 (1.08%)
price chart
Why Earnings Season Could Be Great for Pfizer (PFE)
Investors are always looking for stocks that are poised to beat at earnings season and Pfizer Inc. (PFE - Analyst Report) may be one such company.
Pfizer Inc. (PFE) Looks For Other Acquisition Targets After Teva ...
Pfizer Inc. (NYSE:PFE) is looking to acquire companies to contribute to its revenue growth, and the hunt has become rather aggressive after Israel-based Teva Pharmaceutical Industries Ltd (NYSE:TEVA) rejected the company's acquisition offer, as per ...
What to Expect When Pfizer (PFE) Reports Fourth-Quarter Earnings Tomorrow
Pfizer's $33 Billion Cash Pile Has Everyone Guessing  Bloomberg
Here's What Pfizer Inc. Could Do With Its $33 Billion Cash Pile
The pharmaceutical giant's balance sheet has been a core focus for the market ever since Pfizer had to walk away from acquiring UK-based AstraZeneca plc in a deal worth $120 billion.
Pfizer to Cut Prevenar 13 Price Again
Pfizer Inc. said Monday it would cut the price of its pneumococcal vaccine for the third time in three years as the pharmaceutical industry faces criticism over skyrocketing vaccine prices in developing markets.
Pfizers Prevenar 13 Wins CHMP Backing for Expanded Use
Market Update (NYSE:PFE): Pfizer Commits to Further Reduce Price for ...  Jutia Group
Analyst Update: Goldcorp Inc., Pfizer Inc., and Yahoo! Inc.
Analysts are weighing in today on gold producer Goldcorp Inc. (USA) (NYSE:GG), pharmaceutical titan Pfizer Inc. (NYSE:PFE), and Internet heavyweight Yahoo!
Pfizer Inc. (PFE), Alliance HealthCare Services, Inc. (AIQ), Skilled ...
Anders Hallberg and Carl Bennet's HealthInvest Partners AB revealed its top picks for the fourth quarter of 2014. According to the 13F Form filed with the U.S.
Let Me Tell You A Story About Pfizer
As an aside, there are two other businesses in the reorganized company: Global Innovative Pharma and Global Vaccines, Oncology and Consumer Healthcare.
Will Pfizer Inc. (PFE) Earnings Continue To Top Expectations?
Pfizer Inc. (NYSE:PFE) will be releasing its financial numbers on Tuesday before the market opens. All eyes are on the stock since its earnings topped the Street analysts' predictions at least in the last four quarters.
One Put, One Call Option To Know About for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer PFE +1.05% Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Trade of the Day: A Defensive Play Even Traders Can Love � PFE Stock
S&P Capital IQ, which has a $37 price target on PFE stock, estimates the company will post operating earnings per share (EPS) of $2.25 in 2014, up from $1.65 in 2013.
Pfizer Inc. (NYSE:PFE) Blamed for Overpricing with GlaxoSmithKline plc ...  StreetWise Report
Morningstar Assigns AA- Credit Rating to Pfizer (PFE)  The Legacy